Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFD Technologies Regulatory News (FDP)

  • This share is currently suspended. It was suspended at a price of 2,450.00
  • There is currently no data for FDP

AGM Statement

8 Jul 2020 07:00

RNS Number : 3106S
First Derivatives PLC
08 July 2020
 

8 July 2020

 

First Derivatives plc

("FD" or the "Group")

 

AGM Statement

 

FD (AIM: FDP.L, Euronext Growth: FDP.I) issues the following statement ahead of its Annual General Meeting which will take place at 2.30pm today. The statement provides an update on the Group's progress in the current financial year for the four months ending 30 June 2020.

 

Total revenue was 6% ahead of the prior year period, reflecting the Group's resilience during a period impacted by COVID-19 across our operations. Managed services and consulting revenue was up 2% on the prior year period as we continued to benefit from the high visibility and repeat nature of our client engagements. As expected there has been some deferral of new project engagements, the financial impact of which to date has been partially mitigated by lower recruitment and cost management.

 

Software revenue increased by 8%, led by growth in recurring license and subscription revenue. This was offset by a small decline in perpetual license revenue as new software sales continue to take longer to close in the current climate.

 

Cash generation during the period was in line with expectations.

 

The Board continues to believe that it is still too soon to determine the likely outcome for the full year but is encouraged by performance to date and will continue to invest to deliver against the market opportunity. The Group remains strategically well placed and we are encouraged by the growing demand for Kx streaming analytics from potential customers and partners.

 

Further updates will be provided as the year progresses.

 

Enquiries

For further information please contact:

First Derivatives plc

Seamus Keating, Chief Executive Officer

Graham Ferguson, Chief Financial Officer

Ian Mitchell, Head of Investor Relations

+44(0)28 3025 2242

www.firstderivatives.com

 

 

Investec Bank plc (Nominated Adviser and Broker)

Andrew Pinder

Carlton Nelson

Sebastian Lawrence

+44 (0) 20 7597 5970

 

 

Goodbody (Euronext Growth Adviser and Broker)

David Kearney

Don Harrington

Finbarr Griffin

+353 (0)1 667 0420

 

 

FTI Consulting

Matt Dixon

Dwight Burden

Darius Alexander

 

+44 (0) 20 3727 1000

About FD

FD is a global technology provider with more than 20 years of experience working with some of the world's largest finance, technology, automotive, manufacturing and energy institutions. The Group's Kx technology, incorporating the kdb+ time-series database, is a leader in high-performance, in-memory computing, streaming analytics and operational intelligence. Kx delivers the best possible performance and flexibility for high-volume, data-intensive analytics and applications across multiple industries. FD operates from 15 offices across Europe, North America and Asia Pacific, including its headquarters in Newry, and employs more than 2,400 people worldwide.

 

For further information, please visit www.firstderivatives.com and www.kx.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGMRRMFTMTBMBAM
Date   Source Headline
11th Feb 20144:18 pmRNSDirector's Shareholding
10th Feb 20147:00 amRNSIssue of Equity
6th Feb 20147:00 amRNSOpening of Singapore Office
20th Jan 20147:00 amRNSDirector/PDMR Shareholding
31st Dec 201311:08 amRNSTotal Voting Rights
20th Dec 20134:33 pmRNSIssue of Equity
5th Dec 20137:00 amRNSEnterprise Securities Market Notice
29th Nov 20134:00 pmRNSIssue of Equity
26th Nov 20137:00 amRNSASIC goes live with new surveillance system
5th Nov 20137:00 amRNSInterim Results
23rd Oct 20137:00 amRNSNotice of Results
30th Sep 20131:34 pmRNSTotal Voting Rights
18th Sep 20131:01 pmRNSCollaboration with NYSE Technologies
11th Sep 20137:00 amRNSEnterprise Securities Market Notice
10th Sep 20137:00 amRNSContract Win
5th Sep 20132:41 pmRNSIssue of Equity
30th Aug 20131:05 pmRNSTotal Voting Rights
21st Aug 20137:00 amRNSDelta Stream Selected by Communications Provider
14th Aug 20137:00 amRNSEnterprise Securities Market Notice
8th Aug 201312:53 pmRNSIssue of Equity
18th Jul 201312:55 pmRNSResult of AGM
9th Jul 20137:00 amRNSEnterprise Securities Market Notice
5th Jul 20134:11 pmRNSHolding(s) in Company
5th Jul 20134:10 pmRNSHolding(s) in Company
3rd Jul 20133:18 pmRNSIssue of Equity
3rd Jul 20137:00 amRNSEnterprise Securities Market Notice
28th Jun 20137:00 amRNSPlacing of 840,000 new ordinary shares
18th Jun 20137:00 amRNSFinal Results
5th Jun 20137:00 amRNSNotice of Results
9th May 20137:00 amRNSBoard restructuring
30th Apr 20138:00 amRNSTotal Voting Rights
26th Apr 20133:54 pmRNSEnterprise Securities Market Notice
23rd Apr 20137:00 amRNSEnterprise Securities Market Notice
19th Apr 20137:30 amRNSChange in Directors Shareholding
19th Apr 20137:30 amRNSGrant of Options
17th Apr 20133:10 pmRNSIssue of Equity
3rd Apr 20133:40 pmRNSDirector's Shareholding
2nd Apr 20137:00 amRNSPre-close period trading update
15th Mar 20137:00 amRNSSEF initiative & Compliance Officer appointment
28th Feb 20137:00 amRNSTotal Voting Rights
11th Feb 20137:00 amRNSEnterprise Securities Market Notice
6th Feb 20137:00 amRNSExercise of Options
4th Jan 20133:41 pmRNSDirector/PDMR Shareholding
13th Dec 20127:00 amRNSContract win
10th Dec 20127:00 amRNSDirectorate Change
30th Nov 20127:00 amRNSTotal Voting Rights
16th Nov 20127:00 amRNSEnterprise Securities Market Notice
14th Nov 20127:00 amRNSDirector shareholding
13th Nov 20127:00 amRNSDirector shareholding
12th Nov 20123:24 pmRNSExercise of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.